Skip to main content
. 2010 May 12;30(19):6743–6750. doi: 10.1523/JNEUROSCI.1381-10.2010

Figure 7.

Figure 7.

γ-Secretase inhibition modulates levels of Aβ 1-14, 1-15, 1-16, and 1-17. Rhesus monkeys (n = 6, n = 3/group) were treated with either vehicle (black, circle) or 240 mg/kg GSI (red, triangle). An increase in levels of Aβ 1-14 (A), Aβ 1-15 (B), and Aβ 1-16 (C) was observed in GSI versus vehicle-treated animals during γ-secretase inhibition. However, levels of Aβ 1-17 (D) in treated animals were decreased versus vehicle. The means of the vehicle versus treated animals over 48 h were significantly different for Aβ 1-14 (A), Aβ 1-15 (B), Aβ 1-16 (C), and Aβ 1-17 (D) (unpaired t test p < 0.0001).